Research & Publications

Research Experience

• 2015 - Present - Phase II, A Double-Blind, Controlled Phase 2B Study of the Safety and Efficacy of Modified Stem Cells in Patients with Chronic Motor Deficit from Ischemic Stroke, Principal Investigator
• 2015 - Present - Phase III, A DB, PC, study for safety and efficacy of XXX in patients with IBS-C; Sub-Investigator
• 2015 - Present - Phase II, Randomized, DB, PC, study to evaluate the safety and efficacy of XXX administered to patients with vomiting symptoms and moderate to severe diabetic gastroparesis; Sub-Investigator
• 2015 - Present - Phase III, A Phase 3, Randomized, Double Blind, Placebo Controlled Study of the Efficacy and Safety of XXXX for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis; Sub-Investigator
• 2015 - Present - Phase II, A multi-center, randomized, double-blind, placebo-controlled study of investigational drug capsules in patients with chronic idiopathic constipation-Sub Investigator-Under contract Negotiations
• 2013 -2015 - Phase III, Randomized, Multicenter, DB, PC, To evaluate the Safety and Efficacy of XXX in the treatment of Opioid Induced Constipation in Subjects with non-malignant chronic pain, Principal Investigator
• 2013 - 2015 - Phase III, Multicenter, Randomized, DB, PC, Study to Evaluate the Efficacy and Safety of XXX for the Treatment of Opioid Induced Constipation, Sub-Investigator
• 2013 - Observational Study, evaluate the effectiveness, long-term safety, tolerability, satisfaction with treatment, and health-related quality of life (HRQoL) associated with Intrathecal XXXX use for severe chronic pain of varying etiologies, Sub-Investigator
• 2013 - 2014 - A Randomised, Double-Blind, Study to Prevent Major Vascular Events With XXXX Compared to Aspirin (ASA) in Patients With Acute Ischemic Stroke or TIA, Sub-Investigator
• 2011 - 2012 - A Randomized, DB, DD, PC, PG, Multicenter Trial of XXXX CR Tablets to Assess The Analgesic Efficacy and the Management of Opioid Induced Constipation in Opioid-experienced Subjects with uncontrolled moderate to severe Chronic Low Back pain and a History of Opioid Induced Constipation, Sub-Investigator
• 2005 - 2006 - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Efficacy Study of XXXX Capsules in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Hip or Knee, Sub-Investigator
• 2005 - Treatment of Chronic Cough using Botulinum Toxin under EMG Guidance, Principal Investigator
• 2002 - Use of GM-CSF in Diabetic Foot Ulcers case-controlled study, Investigator
• 2001 - Retrospective Study for the Non-Operative Management of Liver Injuries, Principal Investigator
• 2001 - Study to Evaluate the Effects of Blunt Trauma in Small Bowel Injury, Principal Investigator
• 2000 - Study Predicting Outcomes after Blunt Trauma in Head Injuries, Principal Investigator
• 2000 - A Study of Substance Abuse Under-detection by Physicians, Principal Investigator
• 2000 - Study of the Incidence of Substance Abuse amongst Adolescents and Teenagers, Principal Investigator
• 1998 - Phase III, A Multicenter, Randomized, DB, PC, Trials for the Treatment of H.Pylori Infection, Principal Investigator
• May 1997- March 1998 - HIV CARES Project, Research Associate

Research Publications

• April 2004 - Chronic cough due to Laryngeal Hypertonicity Treated with Botulinum Toxin A. Paper presented at the Virginia society of Otolaryngology meeting Williamsburg, VA April. John D. Lieser, MD, Nadeem A Khan, MD et al.
• April 2002 - Trauma Scores: Recent Advances- Chapter written for TEXTBOOK "Thoracic Trauma and Critical Care"
• May 2000 - Substance Abuse Under-Detection in Adolescents by Physicians, Johns Hopkins SPH Journal
• May 2000 - Substance Abuse in Adolescents and Teenagers, Johns Hopkins SPH Journal
• August 1999 - Ethics and Patients Confidentiality, Johns Hopkins SPH Journal
• December 1998 - Diarrhea, A Public Health Problem for Developing and Developed Countries